Evonik reorganizes its polyamide business
Evonik is reorganizing its business for high-performance polymers within the polyamide group. The specialty chemicals company has already begun construction of a new polyamide 12 (PA 12) facility complex and is expanding its production of transparent polyamides at the Marl Chemical Park, and, in so doing, is concentrating its activities on high-performance materials for attractive growth markets such as the automotive, oil and gas, 3D printing, and optics industries. As part of the reorganization process, Evonik will withdraw entirely from the polyphthalamide (PPA) business at the Witten site.
Focusing on specialty materials
“Reorganizing our polyamide business will concentrate our production and innovative strengths on specialty materials for promising applications in attractive markets such as lightweight construction, additive manufacturing, and composites. This, in turn, will give us a solid foundation for continuous growth,” says Dr. Ralf Düssel, the head of the High Performance Polymers Business Line at Evonik. “For our customers, the move will mean a more intense focus on developing sophisticated specialty solutions.”
Evonik’s roughly €400 million investment in Germany will increase the company’s overall capacity for PA 12 by over 50 percent. The project will complement existing PA 12 production at the Marl Chemical Park in the state of North Rhine-Westphalia with additional plants for the polymer and its precursors. The facility complex is scheduled to go on stream in the first half of 2021.
At the same time, Evonik will also be expanding production of transparent polyamides in Marl. Production expansion is slated for completion in the first quarter of 2020. The change will double the specialty chemicals company’s overall capacity for the high-performance material.
In another step in the process of reorganizing its polyamide business, Evonik will be discontinuing the production and sale of polyphthalamide at its Witten site by the end of the first quarter of 2020. Evonik will transfer employees from the PPA plant to its Marl site, where they will work at the new PA 12 production plant.
“As we focus our marketing activities on high-performance polymers, we will be utilizing internal synergies to accommodate our long-serving Witten employees with secure jobs at the new polyamide 12 production facility in Marl, where we will be able to draw upon their decades of proven experience in polymer production and compounding,” says Dr. Iordanis Savvopoulos, Head of the Product Line Granules & Compounds at Evonik.
Evonik currently employs almost 300 people in Witten. The specialty chemicals company operates several production facilities for the production of organic substances on the approximately 16-hectare site which is one of the major production sites of raw materials for the paints, coatings and adhesives industry. In 2018, the group’s new production plant for specialty copolyesters at the Witten site went on stream.
Biopolymers complement the product portfolio
Biobased polymers from the Terra series remain in the business portfolio and will continue to complement Evonik’s now reorganized range of high-performance polymers.
Evonik has over 50 years of experience in developing and manufacturing high-performance plastics. The company’s comprehensive product portfolio encompasses solutions for virtually any industrial application.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales from continuing operations in Asia Pacific North reached €1.97 billion in 2018. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.